India’s Appasamy Acquires German Ophthalmic Technology Company RUCK to Expand Global Eye Surgery Equipment Business

Chennai-headquartered medical technology manufacturer Appasamy Associates has acquired German ophthalmic surgical equipment company RUCK GmbH, strengthening its presence in the international eye care technology industry. The acquisition brings advanced German-developed surgical systems into Appasamy’s expanding product portfolio and supports the Indian company’s ambition to become a leading global manufacturer of ophthalmic surgical equipment.

Announced on 22 October 2026, the acquisition adds RUCK’s specialised phaco-vitrectomy technology to Appasamy’s existing capabilities in intraocular lenses, ophthalmic instruments, diagnostic equipment and surgical systems. The German company brings more than four decades of experience in the development of equipment used for cataract and vitreoretinal surgery.

The transaction also strengthens Appasamy’s international technological capabilities. RUCK will retain its engineering and product development operations in Germany while gaining access to the Indian company’s manufacturing expertise, resources and extensive international distribution network.

German Ophthalmic Technology Manufacturer Joins Indian Medical Technology Group

RUCK GmbH, headquartered in Eschweiler, Germany, specialises in developing ophthalmic surgical systems and associated medical technologies. Established in 1981, the company has built expertise in equipment designed for surgical procedures involving both the anterior and posterior segments of the eye.

Its product portfolio includes the Pentasys, Qube and Qube Pro surgical platforms, which support cataract and vitreoretinal procedures. These systems have established a presence among ophthalmic surgeons in Germany and the Benelux region, comprising Belgium, the Netherlands and Luxembourg.

Over several decades, RUCK has developed its products through collaboration with ophthalmologists, medical specialists and international technology partners. This approach has supported the development of surgical equipment designed to meet the technical requirements of specialised eye procedures.

The acquisition allows Appasamy to incorporate RUCK’s engineering expertise and established technologies into its wider ophthalmic equipment business. The combination will also support continued development of the German company’s existing surgical systems and future product offerings.

Qube Pro Surgical Platform Strengthens Appasamy’s Technology Portfolio

A major technological component of the acquisition is RUCK’s flagship Qube Pro surgical platform, which supports procedures involving both the anterior and posterior segments of the eye.

The anterior segment includes structures such as the cornea, iris and lens, while the posterior segment contains important structures including the vitreous body and retina. Surgical procedures involving these areas require specialised instruments capable of performing precise operations within delicate ocular tissues.

Qube Pro incorporates technologies used in phacoemulsification and vitrectomy procedures. Phacoemulsification is commonly employed during cataract surgery to break up and remove the eye’s clouded natural lens. Vitrectomy involves removing vitreous gel from the eye to enable treatment of certain retinal and vitreous conditions.

A combined phaco-vitrectomy platform provides ophthalmic surgeons with equipment capable of supporting different types of procedures through an integrated surgical system.

For Appasamy, adding this technology broadens its existing capabilities and creates opportunities to offer a more comprehensive range of equipment for specialised ophthalmic surgery.

Acquisition Addresses Demand for Advanced Eye Surgery Equipment in India

Appasamy Chief Executive Officer Senthil Kumar described the acquisition as an important step towards developing a broader international surgical ophthalmology business.

He highlighted the demand in India for dependable, CE-marked phaco-vitrectomy equipment and identified RUCK’s Qube Pro platform as a technology capable of addressing this requirement.

CE marking indicates that a product meets applicable European regulatory requirements for its intended market. For medical equipment, the relevant requirements include safety, performance and regulatory conformity under the applicable European framework.

The addition of Qube Pro gives Appasamy an opportunity to introduce specialised surgical technology to a wider network of ophthalmic professionals in India.

India has a substantial requirement for eye care services, including cataract treatment and procedures involving retinal disorders. The availability of advanced surgical equipment contributes to the ability of ophthalmic institutions to undertake specialised procedures.

Through the acquisition, Appasamy intends to expand access to these technologies while continuing to strengthen its established portfolio of surgical instruments and ophthalmic devices.

Appasamy’s Network Reaches More Than 20,000 Ophthalmologists in India

Appasamy Associates has developed an extensive presence in India’s ophthalmic equipment industry, supplying products to hospitals, eye care institutions and medical professionals.

According to the company’s leadership, its professional network covers more than 20,000 ophthalmologists across India, providing a substantial platform for introducing specialised surgical technologies.

Arvind Kasthuri, President of Innovation and Technology at Appasamy, stated that RUCK’s Qube Pro platform and associated consumables would deepen the group’s ophthalmic technology portfolio.

The acquisition will enable Appasamy to offer additional products for both anterior and posterior segment surgical procedures while strengthening its engagement with ophthalmologists who require specialised equipment.

The company’s established network also provides opportunities for RUCK’s technologies to reach new healthcare institutions and surgical centres.

By combining German-developed systems with an Indian distribution and service network, the group intends to expand the availability of specialised ophthalmic surgical equipment.

Chennai-Based Appasamy Builds an International Ophthalmic Manufacturing Business

Founded in 1978, Appasamy Associates has grown from an Indian ophthalmic equipment manufacturer into a medical technology group with an expanding international presence.

Its product portfolio includes intraocular lenses, cataract surgery equipment, diagnostic instruments, ophthalmic lasers, microsurgical instruments and associated medical devices.

Intraocular lenses are artificial lenses implanted in the eye, most commonly following the removal of a cataract-affected natural lens. The development and manufacture of these devices represent an important segment of the ophthalmic medical technology industry.

Appasamy manufactures approximately five million intraocular lenses annually, and more than 100 million of its lenses have been implanted worldwide, according to company information.

Its products are distributed across more than 100 countries, demonstrating the international reach of the Chennai-based manufacturer.

The acquisition of RUCK further expands the company’s technological capabilities beyond its established products and strengthens its participation in higher-value ophthalmic surgical equipment.

German Engineering and Research Operations to Remain in Germany

An important feature of the acquisition is Appasamy’s decision to retain RUCK’s engineering and product development operations in Germany.

The arrangement allows the German manufacturer to preserve its established technical expertise while benefiting from the resources and international reach of the larger Indian group.

Germany has a long history of specialised engineering and medical technology manufacturing. RUCK’s experience in ophthalmic surgical equipment adds an important technological component to Appasamy’s international research and development capabilities.

The company has already established medical technology centres of excellence in Denmark and San Francisco, United States. The addition of RUCK’s German engineering operations further expands this international network.

The combined technological base will support collaboration among engineering teams working on ophthalmic surgical systems, instruments and related medical devices.

This approach allows Appasamy to combine specialised expertise from different international locations while coordinating product development within a broader corporate structure.

RUCK to Expand International Reach Through Appasamy

RUCK Chief Executive Officer Florian Becker welcomed the acquisition, highlighting Appasamy’s established international presence and understanding of ophthalmic surgery.

He indicated that the partnership would support continued development of the Qube Pro platform while creating opportunities to introduce RUCK’s technologies to additional surgeons internationally.

The German company will gain access to Appasamy’s distribution capabilities and broader medical technology portfolio, allowing its specialised products to reach markets beyond their established European customer base.

Michael Ruck, a member of the founding family and former Chief Executive Officer, also welcomed the transaction, highlighting the shared emphasis on engineering quality and technological development.

The continued presence of the founding company’s engineering operations in Germany will help preserve the technical knowledge developed over more than four decades.

The acquisition therefore combines RUCK’s specialised product expertise with Appasamy’s wider manufacturing, commercial and international distribution capabilities.

Warburg Pincus-Backed Appasamy Advances Global Expansion

Appasamy Associates is backed by global investment firm Warburg Pincus, which acquired a controlling stake in the Indian medical technology manufacturer in 2024.

The investment supported Appasamy’s plans to strengthen its position in the ophthalmic equipment industry and expand its international operations.

The acquisition of RUCK represents a further development in this expansion strategy, adding established European medical technology capabilities to the company’s business.

International acquisitions can provide manufacturers with access to specialised engineering expertise, established product portfolios and distribution networks in markets where developing comparable capabilities independently may require considerable time.

For Appasamy, the transaction brings together complementary technologies rather than simply expanding its geographical presence.

The addition of advanced surgical platforms also allows the company to strengthen its position across different segments of ophthalmic care, from intraocular lenses and diagnostic equipment to complex surgical systems.

Indian Medical Technology Industry Expands Its Global Capabilities

Appasamy’s acquisition of RUCK reflects the increasing international ambitions of Indian medical technology manufacturers.

India has developed considerable capabilities in pharmaceutical manufacturing, medical devices, precision engineering and healthcare equipment. Companies operating in these sectors are increasingly exploring opportunities to strengthen their technological expertise and expand into international markets.

Acquiring specialised overseas manufacturers can provide Indian companies with established intellectual property, engineering experience and access to mature product platforms.

Such transactions also create opportunities for collaboration between Indian manufacturing operations and international research and development centres.

In ophthalmic technology, manufacturers must continuously improve surgical precision, equipment reliability, system integration and ease of operation.

By combining its existing manufacturing experience with German expertise in phaco-vitrectomy technology, Appasamy is strengthening its ability to participate in this specialised international medical equipment market.

The development illustrates how Indian companies are progressing from domestic manufacturing towards the ownership and development of advanced medical technology platforms.

Appasamy Strengthens India’s Presence in Global Ophthalmic Technology

The acquisition of RUCK GmbH represents an important milestone in Appasamy Associates’ evolution as an international ophthalmic medical technology manufacturer.

The transaction adds established German-developed surgical systems, including the Qube Pro platform, to the Chennai-based company’s product portfolio. It also expands Appasamy’s international engineering network while preserving RUCK’s specialised research and development capabilities in Germany.

The combined organisation intends to strengthen the availability of advanced ophthalmic surgical technologies in India and other international markets.

For India’s medical technology industry, the acquisition demonstrates the growing capacity of domestic manufacturers to expand globally through specialised technology partnerships and international acquisitions.

With established manufacturing operations in India, technological centres in Europe and the United States, and an extensive international customer network, Appasamy continues to develop a broader presence in the global ophthalmic equipment industry.

The integration of RUCK’s technologies strengthens this foundation and supports the company’s long-term objective of developing advanced surgical systems for ophthalmologists worldwide.

---

References

1. Appasamy Associates and RUCK GmbH. Corporate announcement concerning Appasamy’s acquisition of RUCK, 22 October 2026. Executive statements from Senthil Kumar, Arvind Kasthuri, Florian Becker and Michael Ruck reproduced in industry reporting.
2. Pharmabiz. Warburg Pincus Backed Appasamy Acquires RUCK. 23 October 2026.
   https://www.pharmabiz.com/NewsDetails.aspx?aid=191430&sid=2
3. BioSpectrum India. Warburg Pincus-Backed Appasamy Acquires German Manufacturer of Ophthalmic Surgical Products. 22 October 2026.
   https://www.biospectrumindia.com/news/16/28698/warburg-pincus-backed-appasamy-acquires-german-manufacturer-of-ophthalmic-surgical-products-.html
4. Appasamy Associates. Official corporate website, ophthalmic surgical systems and medical technology portfolio.
   https://www.appasamy.com/
5. RUCK Ophthalmologische Systeme GmbH. Corporate information and ophthalmic surgical technology portfolio, including Pentasys, Qube and Qube Pro systems.

---